Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Accounts Payables (2020 - 2025)

Historic Accounts Payables for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • MDxHealth's Accounts Payables fell 959.08% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 959.08%. This contributed to the annual value of $8.0 million for FY2024, which is 919.31% down from last year.
  • Latest data reveals that MDxHealth reported Accounts Payables of $9.4 million as of Q3 2025, which was down 959.08% from $6.7 million recorded in Q2 2025.
  • MDxHealth's Accounts Payables' 5-year high stood at $12.1 million during Q2 2024, with a 5-year trough of $6.7 million in Q2 2025.
  • Its 5-year average for Accounts Payables is $9.3 million, with a median of $9.2 million in 2023.
  • As far as peak fluctuations go, MDxHealth's Accounts Payables skyrocketed by 4013.16% in 2021, and later plummeted by 4444.99% in 2025.
  • Over the past 5 years, MDxHealth's Accounts Payables (Quarter) stood at $7.5 million in 2021, then soared by 36.53% to $10.2 million in 2022, then decreased by 13.43% to $8.8 million in 2023, then fell by 9.19% to $8.0 million in 2024, then grew by 17.35% to $9.4 million in 2025.
  • Its Accounts Payables was $9.4 million in Q3 2025, compared to $6.7 million in Q2 2025 and $7.6 million in Q1 2025.